Supermoon Capital is a San Francisco-based venture capital firm and the first fund exclusively focused on the sleep and circadian rhythm market. It invests in early-stage companies building science-backed sleep solutions across healthcare and consumer technology.
50% of their portfolio is in Healthcare. Their most common stage is series-a (40% of deals). Average disclosed round size is $27.1M (across 8 rounds with reported amounts).
Portfolio
7
Fund Size
$36M
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Mosanna Therapeutics | Series A | $80M | Jun 2025 |
| MMosanna | Series A | $80M | Jan 2025 |
 Arctop | Series A | $10M | Oct 2023 |
| MMosanna | Seed | — | Apr 2023 |
| Mosanna Therapeutics | Seed | — | Apr 2023 |
 EnsoData | Series A | $20M | Jun 2022 |
 Sahha | Growth | $1.2M | Jan 2021 |
 Arcascope | Seed | $2.9M | — |
 Aesyra | Seed | $3M | — |
| EnsoData | Series B | $20M | — |
Top Co-Investors
High-Tech Gründerfonds4 shared
EQT Life Sciences2 shared
Forbion2 shared
Pivotal Life Sciences2 shared
Broadview Ventures2 shared
Norwest Venture Partners2 shared
Zetta Venture Partners2 shared
CIBC Innovation Banking2 shared
Colle Capital2 shared
Fifth Growth Fund1 shared
Necessary Ventures1 shared
gener8tor1 shared
Blackbird1 shared
Antler1 shared
Inflect Health1 shared
Zürcher Kantonalbank1 shared
Last updated: 20 October 2026